skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine (Code C70644)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine

Definition: A cancer vaccine, consisting of alphavirus vector-derived virus-like replicon particles expressing the 9-amino-acid carcinoembryonic antigen peptide (CAP) 1-6D, with potential antineoplastic activity. Vaccination with this agent may elicit a cytotoxic T lymphocyte (CTL) immune response against CEA-expressing tumor cells.

Display Name: Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine

Label: Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine

NCI Thesaurus Code: C70644 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL375947  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
AVX701
Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine
CEA(6D) VRP

External Source Codes: 
PDQ Closed Trial Search ID 570689
PDQ Open Trial Search ID 570689 (check for NCI PDQ open clinical trial info)
NCI META CUI CL375947

Other Properties:
     Name Value (qualifiers indented underneath)
code C70644
Contributing_Source CTRP
Legacy_Concept_Name CEA-6D_VRP_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C70644

Mainbox Bottom